Nephros, Inc.
NEPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $5 | $4 | $5 | $4 |
| % Growth | 7.8% | -9.4% | 26% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $1 |
| Gross Profit | $3 | $3 | $3 | $2 |
| % Margin | 61.2% | 63.2% | 64.7% | 64% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $3 | $3 | $2 |
| Operating Income | $0 | $0 | $1 | $0 |
| % Margin | 6.6% | 5.6% | 11.6% | 8.2% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | $0 |
| Pre-Tax Income | $0 | $0 | $1 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $1 | $0 |
| % Margin | 7.1% | 5.4% | 11.4% | 9% |
| EPS | 0.03 | 0.022 | 0.053 | 0.033 |
| % Growth | 33.9% | -57.4% | 58.9% | – |
| EPS Diluted | 0.03 | 0.022 | 0.053 | 0.033 |
| Weighted Avg Shares Out | 11 | 11 | 11 | 11 |
| Weighted Avg Shares Out Dil | 11 | 11 | 11 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $1 | $0 |
| % Margin | 7.9% | 6.4% | 12.3% | 10.3% |